Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.79 USD | +1.51% | -11.17% | +9.84% |
05-13 | Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program | MT |
05-10 | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.84% | 1.09B | |
+31.37% | 588B | |
-2.76% | 364B | |
+20.66% | 326B | |
+5.66% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.19% | 167B | |
-0.02% | 161B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26